Press Releases
🇺🇸 FDA Page 15FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 169–180 of 212 articles
Adcendo ApS Advances ADCE-T02 Antibody-Drug Conjugate to Expansion Phase, ADCE-D01 Receives FDA Orphan Drug Status
FDA Grants Priority Review to PADCEV-Keytruda Combination for Muscle-Invasive Bladder Cancer Treatment
Philip Morris International Receives FDA Reauthorization for IQOS Modified Risk Tobacco Product
Whitehawk Therapeutics HWK-007 Shows Promise in AACR 2026 ADC Data Presentation
Nuance Pharma's Ohtuvayre Shows Improved Lung Function in Chinese COPD Patients - ENHANCE-CHINA Phase 3 Results Published
Lundbeck's VYEPTI Shows Improvement in Migraine-Related Cognitive Symptoms in Real-World INFUSE Study
Health Canada Approves Bracco's VUEWAY (Gadopiclenol) for Lower-Dose MRI Contrast Imaging
Salubris Biotherapeutics JK06 Shows Promise in Phase 1/2 Cancer Trial at AACR 2024
Innate Pharma IPH5201 MATISSE Phase 2 Results Selected for AACR 2026 Clinical Trials Plenary Session
Accent Therapeutics ATX-295 Shows Promising Anti-Cancer Activity in Preclinical Studies at AACR 2026
Zai Lab's ZL-1503 Bispecific Antibody Shows Rapid Itch Relief in Atopic Disease Preclinical Studies
Zai Lab's ZL-1503 Bispecific Antibody Shows Promise for Rapid Itch Relief in Atopic Dermatitis Preclinical Study